Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions


Latest Cancer News

More Risk than Benefit with TSH Suppression in Thyroid Cancer without High Risk of Recurrence (May 21, 2015)

For patients undergoing treatment for thyroid cancer who aren’t at high risk of recurrence, therapy to suppress thyrotropin (TSH) may be ineffective as well as risky. These findings were published in... Continue Reading

Xilonix™ Promising as Treatment for Non–Small Cell Lung Cancer (May 20, 2015)

The new targeted agent Xilonix™ appears effective in the treatment a non–small cell lung cancer (NSCLC). The biotechnology company XBoitech Inc recently announced clinical trial findings for the drug.[i],[ii] Xilonix... Continue Reading

Target Therapy Sutent® Promising in Advanced Thyroid Cancer (May 19, 2015)

The targeted therapy Sutent® (sunitinib) appears effective in the treatment of patients with advanced differentiated thyroid cancers. The Endocrine Society announced these Phase II trial findings in a... Continue Reading

Personalized Screening Test for Ovarian Cancer Potentially Game-Changing, says GlobalData (May 18, 2015)

LONDON, UK (GlobalData), 12 May 2015 – The encouraging recent results of a 14-year study by the UK Collaborative Trial of Ovarian Cancer Screening could herald a radical departure from the approach... Continue Reading

Reolysin® Receives FDA Designation for Gastric Cancer (May 14, 2015)

The U.S. Food and Drug Administration (FDA) has granted an Orphan Drug Designation (ODD) to Reolysin®, an injectable cancer-killing virus, for the treatment of gastric cancer. Oncolytics Biotech® Inc.... Continue Reading

Statin Drugs Can Delay Prostate Cancer in Patients Receiving Androgen Deprivation Therapy, Study Shows (May 13, 2015)

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn’t take... Continue Reading

Regular Screening of Barrett’s Esophagus Patients Improves Rate of Early Cancer Detection (May 12, 2015)

Patients with Barrett’s esophagus who undergo regular exams have an improved chance that precancerous changes and esophageal cancer will be detected early. These findings were published in the journal... Continue Reading

Personalized Immunotherapy Delays Recurrence in Ovarian Cancer (May 11, 2015)

A new immunotherapy known as Vigil™ may help delay the recurrence of advanced ovarian cancer. These findings were presented at the 2015 Annual Meeting on Women’s Cancer, March 28–31, in Chicago,... Continue Reading

Adcetris® after Stem Cell Transplant Improves Survival in Hodgkin’s Lymphoma (May 7, 2015)

For patients with relapsed or refractory Hodgkin’s lymphoma (HL), treatment with  Adcetris® (brentuximab vedotin) after autologous stem cell transplant may improve survival. The Lancet published these... Continue Reading

Revised Phase 3 Study Now Open to More Patients With Colorectal Cancer (May 6, 2015)

AUSTIN, Texas, April 29, 2015 — XBiotech (XBIT), a leading developer of next-generation True Human™ therapeutic antibodies, announced today that it has enrolled the first patient into its revised... Continue Reading

National Brain Cancer Awareness Month on CancerConnect (May 4, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of brain cancer educational programs for national brain cancer awareness month. As the month of May brings brain... Continue Reading

Melanoma Drug T-VEC Receives Recommendation for FDA Approval (May 1, 2015)

An advisory panel to the U.S. Food and Drug Administration (FDA) has recommended approval of the investigational drug T-VEC (talimogene laherparepvec) for the treatment of metastatic melanoma. Biopharmaceutical... Continue Reading

National Melanoma Awareness Month on CancerConnect (May 1, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of melanoma educational programs for national melanoma awareness month. As the month of May brings melanoma into... Continue Reading

Dose-Dense Chemotherapy with Ellence®, Cytoxan®, and Taxol® May Improve Survival in Node-Positive Breast Cancer (April 30, 2015)

Patients with early-stage node-positive breast cancer who receive dose-dense adjuvant chemotherapy with Ellence® (epirubicin), Cytoxan® (cyclophosphamide), and Taxol® (paclitaxel) may have improved... Continue Reading

Ask the Expert: Polycythemia Vera (April 29, 2015)

  Polycythemia vera (PV) expert, Ruben A. Mesa, MD, recently answered our questions and provided an overview of PV. Dr. Mesa is a medical oncologist at the Mayo Clinic in Scottsdale, AZ. He is committed... Continue Reading

Combination of Avastin®, Taxol®, and Carboplatin Improves Survival in Recurrent Platinum-Sensitive Ovarian Cancer (April 29, 2015)

The addition of Avastin® (bevacizumab) to Taxol® (paclitaxel) and carboplatin for the treatment of recurrent platinum-sensitive ovarian cancer appears to improve survival. These findings were presented... Continue Reading

EGFR Testing in Advanced Lung Cancer Appears Underutilized (April 28, 2015)

The results of a recent survey suggest that nearly a quarter of advanced lung cancer patients fail to receive epidermal growth factor receptor (EGFR) testing before starting treatment. The recent development... Continue Reading

Study Demonstrates Superiority Of Kyprolis® over Velcade® in Patients With Relapsed Multiple Myeloma (April 27, 2015)

The results from a planned interim analysis of the Phase 3 head-to-head clinical trial ENDEAVOR evaluating Kyprolis® (carfilzomib in combination with low-dose dexamethasone versus Velcade® (bortezomib)... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions

Cancer Types

Headline News by Cancer Type

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS